MRNA Stock Analysis: Buy, Sell, or Hold?
MRNA - Moderna, Inc. Common Stock
$44.07
-2.79 (-5.95%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 13, 2026
12d
Get Alerted When MRNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
7 traders called MRNA this week
86% bullish • 1 bearish
86% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MRNA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MRNA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MRNA is currently trading at $44.07, which is considered slightly high relative to its 30-day fair value range of $31.83 to $45.43.
Technical Outlook: Technically, MRNA is in a strong uptrend. Immediate support is located at $40.55, while resistance sits at $55.20. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $37.70. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MRNA is in a strong uptrend. Immediate support is located at $40.55, while resistance sits at $55.20. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $37.70. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$31.83 -
$45.43
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.1%
Protect Your Profits
Holding MRNA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.0%)
- BEARISH: Trading 19.5% above Wall St target ($37.70)
- CAUTION: 5-day price weakness (-9.5%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$31.83 -
$45.43
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$40.55
Resistance Level
$55.20
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-6.77
Wall Street Target
$37.70
(-19.5%)
Revenue Growth (YoY)
-45.4%
Earnings Growth (YoY)
-85.1%
Profit Margin
-139.6%
Last updated: January 30, 2026 6:02 PM ET
Data refreshes hourly during market hours. Next update: 7:02 PM
Data refreshes hourly during market hours. Next update: 7:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2025-08-26
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
Advanced MRNA Option Strategies
Professional options setups generated by AI based on today's MRNA price and gamma walls.
